Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    general medicine

    Autoimmune haemolytic anaemia

    Also known as: AIHA, Autoimmune haemolytic anemia, Immune-mediated haemolytic anaemia

    Autoimmune haemolytic anaemia (AIHA) involves antibody-mediated destruction of red blood cells and requires haematological assessment to establish the subtype, severity, and underlying cause. Clinical presentation typically includes fatigue, dyspnoea, jaundice, and dark urine; severe anaemia may require urgent hospital treatment. In clinical settings, TCM may serve as an adjunctive modality for symptom management in medically stable patients; however, acupuncture and herbal medicine must not substitute for pharmacotherapy, blood transfusions, or specialist surveillance. Current literature provides no direct clinical evidence for the efficacy of acupuncture or the listed traditional formulas in treating AIHA. Cited evidence pertains to drug-associated aplastic anaemia, hepatitis B, CAR-T cell therapy, and sinomenine research. These traditional patterns are conceptual references for practitioners and do not constitute evidence-based treatments for haemolysis or substitutes for biomedical diagnosis.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Balance gentle physical activity with rest according to symptomatic tolerance and haematological advice; cease exertion if dyspnoea or dizziness develops.
    • •Maintain regular, nutritionally balanced intake; avoid commencing iron supplementation unless a deficiency is biochemically confirmed and supplementation is explicitly indicated by a medical practitioner.
    • •Patients diagnosed with cold-agglutinin disease or cold-sensitive haemolysis should consult their medical team regarding thermoregulation strategies and the avoidance of cold exposure.
    • •Adhere to all scheduled clinical reviews, maintain an accurate record of all medications and supplements, and follow specialist protocols regarding infection prophylaxis and immunisations during immunosuppressive treatment.

    Cautions & Contraindications

    See sources
    • •Do not assume new or worsening anaemia is necessarily autoimmune or manage it solely through TCM. A medication review is essential, particularly with zidovudine: record [1] reports late severe marrow suppression. Any medicine change must be directed by the prescribing clinician.[]

    When to reassess or seek care again

    See sources

    For medically stable patients only, review supportive care after 1–2 weeks using fatigue and sleep scores, appetite, walking tolerance and adverse effects. Blood-count and haemolysis-marker monitoring must follow the haematologist's schedule, not this adjunctive interval. Stop adjunctive treatment and arrange prompt medical review for worsening symptoms, falling haemoglobin or suspected adverse reactions; use emergency services for acute instability. Discontinue an adjunct without meaningful symptom benefit after 2–4 weeks rather than escalating unproven treatment.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. BMC infectious diseases · 2024
    2. BMJ open · 2026
    3. EBioMedicine · 2026
    4. Heliyon · 2024

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.